Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Ratings
AstraZeneca’s Oncology Breakthroughs: Buy Rating Backed by Promising Pipeline and Strategic Innovations
1d ago
AZN
Premium
The Fly
AstraZeneca’s Imfinzi combination with chemo approved in EU to treat NSCLC
4d ago
AZN
Premium
The Fly
Daiichi Sankyo, AstraZeneca’s Enhertu approved in European Union
4d ago
AZN
Premium
Company Announcements
AstraZeneca’s Imfinzi Regimen Gains EU Approval for Lung Cancer
4d ago
Premium
Company Announcements
EU Approves Enhertu for HER2-Low Breast Cancer Treatment
4d ago
Premium
The Fly
AstraZeneca put volume heavy and directionally bearish
6d ago
AZN
Premium
Company Announcements
AstraZeneca Announces Share Capital and Voting Rights Update
7d ago
Premium
Ratings
AstraZeneca’s Promising Pipeline and Strategic Positioning in Lung Cancer Treatment Earns Buy Rating
7d ago
AZN
Premium
The Fly
AstraZeneca says AZD0780 demonstrates significant LDL-C reduction in trial
8d ago
AZN
Premium
The Fly
AstraZeneca announces FDA approval of Imfinzi combination
8d ago
AZN
Premium
The Fly
AstraZeneca’s Calquence recommended for approval in EU for treatment of MCL
8d ago
AZN
Premium
The Fly
AstraZeneca’s Imfinzi approved in US for treatment of adults with MIBC
8d ago
AZN
Premium
Company Announcements
AstraZeneca’s Calquence Gains EU Recommendation for First-Line Mantle Cell Lymphoma Treatment
8d ago
Premium
Company Announcements
AstraZeneca’s Imfinzi Gains FDA Approval for Bladder Cancer Treatment
8d ago
Premium
The Fly
RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
12d ago
AZN
BMY
Premium
The Fly
BridgeBio announces Japanese MHLW approved acoramidis for treating ATTR-CM
12d ago
AZN
BBIO
Premium
The Fly
U.S. to end funding for child vaccines in developing countries, NY Times reports
13d ago
AZN
GSK
Premium
The Fly
Large pharma M&A deals stalling amid volatile policies, Reuters reports
13d ago
AZN
BMY
Premium
The Fly
AstraZeneca says new results reinforce Tagrisso as backbone therapy
13d ago
AZN
Premium
The Fly
AstraZeneca call volume above normal and directionally bullish
14d ago
AZN
Premium
The Fly
AstraZeneca announces results presented at ELCC on Tagrisso
14d ago
AZN
Premium
The Fly
AstraZeneca to invest $2.5B in Beijing R&D and manufacturing
18d ago
AZN
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
